[1]
Carlino, G., Fornaro, M., Santo, L., Bucci, R., Semeraro, A., Quarta, L., D’Onofrio, F., Marsico, A., Zuccaro, C., Falappone, P., Mazzotta, D., Cantatore, F., Muratore, M. and Iannone, F. 2019. Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE). Reumatismo. 71, 1 (Apr. 2019), 24-30. DOI:https://doi.org/10.4081/reumatismo.2019.1154.